Skip to main content
Log in

Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with Type B hepatitis

Quantitative Messung von HBeAg und anti-HBe mit einem RIA in Seren von chronischen HBsAg-Trägern und Patienten mit Hepatitis B

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

This paper gives the results for HBeAg and anti-HBe titers in chronic HBsAg carriers and patients with type B hepatitis using a “solid-phase” radioimmunoassay.

In tumor and hemodialysis patients the HBeAg titers are statistically significant higher compared to the group of HBsAg positive CAH or CPH.

High anti-HBe titers are a characteristic finding in “healthy” HBsAg carriers. On the other hand, there is a subgroup of HBsAg positive CAH with anti-HBe; although there are signs of an ongoing virus B replication these cases of CAH proceed sometimes to cirrhosis.

Zusammenfassung

In dieser Arbeit werden die Ergebnisse der HBeAg und anti-HBe-Titer Bestimmungen mit einem „solid-phase“-Radioimmunoassay dargestellt.

Bei Tumor- und Hämodialysepatienten sind die HBeAg-Titer statistisch signifikant höher als bei Patienten mit HBsAg positiver CAH oder CPH.

Hohe anti-HBe Titer sind ein charakteristischer Befund für „gesunde“ HBsAg-Träger. Andererseits gibt es eine Untergruppe der HBsAg positiven CAH mit anti-HBe; obgleich bei dieser Form eine CAH keine Zeichen einer fortbestehenden Virus B-Replikation nachgewiesen werden kann, schreitet die Krankheit manchmal in Richtung auf eine Zirrhose fort.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aikawa T, Sairenji H, Furuta S, Kiyosawa K, Shikata T, Imai M, Miyakawa Y, Yanase Y, Mayumi M (1978) Seroconversion from hepatitis Be-antigen to anti-HBe in acute hepatitis B virus infection. N Engl J Med 298:439–441

    Article  PubMed  CAS  Google Scholar 

  2. Arnold W, Meyer zum Büschenfelde KH, Hess G, Knolle J (1975) The diagnostic significance of intrahepaticellular hepatitis-B-surface (HBsAg), hepatitis-B-core-antigen (HBcAg), and IgG for the classification of inflammatory liver diseases. Studies in HBsAg-positive and -negative patients. Klin Wochenschr 53:1069–1074

    Article  PubMed  CAS  Google Scholar 

  3. Arnold W, Nielsen JO, Hess G, Knolle J, Meyer zum Büschenfelde KH (1976) Correlation of the antigen-antibody-system with intrahepatocellular HBcAg and HBsAg in HBsAg-positive acute and chronic liver diseases and healthy HBsAg carriers. Digestion 14:448–449

    Article  Google Scholar 

  4. Arnold W, Meyer zum Büschenfelde KH (1977) Immune complexe of HBcAg/anti-HBc in nuclei of HBsAg-positive chronic liver diseases. N Engl J Med 295:818

    Google Scholar 

  5. Arnold W, Nielsen JO, Hardt F, Meyer zum Büschenfelde KH (1977) Localization of e-antigen in nuclei of hepatocytes in HBsAg-positive liver diseases. Gut 19:994–996

    Google Scholar 

  6. Arnold W, Hess G, Purcell RH, Kaplan P, Gerin JL, Meyer zum Büschenfelde KH (1978) Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases. Klin Wochenschr 56:297–303

    Article  PubMed  CAS  Google Scholar 

  7. Arnold W, Hess G, Dormeyer HH, Gahl G, Hofmann HB, Knolle J, Schönborn H (1979) Radioimmunologischer Nachweis von HBeAg/anti-HBe bei HBsAg positiven Lebererkrankungen und „gesunden“ HBsAg-Trägern. Z Gastroenterol 17:704–712

    PubMed  CAS  Google Scholar 

  8. Arnold W, Hess G, Hütteroth Th, Meyer zum Büschenfelde KH (1980) Immunological status as basis of appropriate treatment in subgroups of HBsAg-positive chronic hepatitis. Scand J Gastroenterol 15:385–388

    PubMed  CAS  Google Scholar 

  9. Berquist KR, Maynard JE, Murphy BL (1976) Infectivity of serum containing HBsAg and antibody to e-antigen. Lancet I:1026–1027

    Article  Google Scholar 

  10. Courouce-Pauty AM, Plancon A (1978) e-Antigen and anti-e in two categories of chronic carriers of hepatitis B surface antigen. Vox Sang (Basel) 34:231–238

    PubMed  CAS  Google Scholar 

  11. Dormeyer HH, Arnold W, Schönborn H, Braun B, Klinge O, Knolle J, Hess G, Kryger P, Nielsen JO, Meyer zum Büschenfelde KH (1981) The prognostic significance of serological, histological and immunohistological findings in asymtomatic HBsAg carriers: A long-term follow-up study of 88 cases. J Infect Dis (in press)

  12. Feinman SV, Berris B, Sinclair JG (1975) e-Antigen and anti-e in HBsAg-carriers. Lancet 2:1173–1174

    Article  PubMed  CAS  Google Scholar 

  13. Fields HA, Bradley DW, Davis CL, Murphy HL, Schable CA, Maynard JE (1978) Radioimmunoassay for the detection of hepatitis e-antigen (HBeAg) and antibody (anti-HBe). J Immunol 121:930–935

    PubMed  CAS  Google Scholar 

  14. Frösner GG, Brodersen M, Papaevangelou G, Sugg U, Haas H, Mushawar IK, Ling CH, Overby LR, Deinhardt F (1978) Detection of HBeAg and anti-HBe in acute hepatitis B by an sensitive radioimmunoassay. J Med Virol 3:67–76

    Article  PubMed  Google Scholar 

  15. Gahl GM, Hess G, Arnold W, Grams G (1979) Hepatitis B-virus markers in 97 long-term hemodialysis patients. Nephron 24:58–63

    Article  PubMed  CAS  Google Scholar 

  16. Hess G, Arnold W, Shih JWK, Kaplan PM, Purcell RH, Gerin JL, Meyer zum Büschenfelde KH (1977) Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers. Infect Immun 17:550–554

    CAS  Google Scholar 

  17. Hess G, Nielsen JO, Arnold W, Meyer zum Büschenfelde KH (1977) e-Antigen-antibody system and intrahepatocellular HBcAg and HBsAg in HBsAg-positive patients with inflammatory liver diseases and healthy HbsAg carriers. Scand J Gastroenterol 12:325–330

    Article  PubMed  CAS  Google Scholar 

  18. Hess G, Wagner J, Arnold W, Purcell RH, Meyer zum Büschenfelde KH (1978) Anti-HBc-titers in HBeAg and anti-HBe-positive asymptomatic HBsAg carriers. Z Immun-Forsch 154:208–217

    CAS  Google Scholar 

  19. Hess G, Arnold W, Meyer zum Büschenfelde KH Serocanversion from hepatitis Be antigen (HBeAg) to anti-HBe after discontinuation of immunosuppressive therapy. (Submitted for publication)

  20. Imai M, Tachibana FC, Moritsugu Y, Miyakawa Y, Mayumi M (1976) E-antigen, Dane particles, and serum DNApolymerase activity in HBsAg carriers. Ann Intern Med 85:458

    Google Scholar 

  21. Kaplan PM, Greenman RL, Gerin JL, Purcell RH, Robinson WS (1973) DNApolymerase associated with human hepatitis B antigen. J Virol 12:995–1005

    PubMed  CAS  Google Scholar 

  22. Kryger P, Mathiesen LR, Møller AM, Aldersville J, Hansson BG, Nielsen JO (1981) Enzyme-linked immunosorbentassay for detection of IgM antibody to the hepatitis Bc-antigen. J Clin Microbiol (in press)

  23. Meyer zum Büschenfelde KH, Hütteroth Th, Arnold W, Hopf U (1979) Immunologic liver injury. The role of hepatitis B-virus antigens and liver membrane antigens as targets. In: Popper H (ed) Progress in liver diseases, Vol VI:407–424

    Google Scholar 

  24. Mushawar IK, Overby LR, Frösner G, Deinhardt F, Ling CM (1978) Prevalence of hepatitis Be-antigen and its antibody as detected by radioimmunoassays. J Med Virol 2:77–78

    Article  Google Scholar 

  25. Nordenfelt E, Andrén-Sandberg M (1976) Dane particle-associated DNApolymerase and e-antigen. Relation to chronic hepatitis among carriers of hepatitis B surface antigen. J Infect Dis 134:85–89

    PubMed  CAS  Google Scholar 

  26. Tabor E, Gerety RJ, Barker LF (1977) Detection of e antigen during acute and chronic hepatitis B virus infection in chimpanzees. J Infect Dis 136:541–547

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Prof. Dr. P. Schölmerich, on his 65th birthday

Supported by the Deutsche Forschungsgemeinschaft, grant no Ar 106/3

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arnold, W., Hess, G., Kawakami, H. et al. Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with Type B hepatitis. Klin Wochenschr 59, 679–683 (1981). https://doi.org/10.1007/BF02593860

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02593860

Key words

Schlüsselwörter

Navigation